A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS
Clinical trial NCT03290131 · COMPLETED
Trial details
- NCT number
- NCT03290131
- Sponsor
- RVL Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-28
- Primary completion
- 2018-12-03
- Enrollment
- 536
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.